A report by the European Commission has shown that the incidence of BSE in continental Europe is now higher than in the UK. Experts are divided however over whether this means that the centre of the epidemic is shifting away from the UK, where the disease was first identified in the 1980s, or if it simply shows that a universal testing method needs to be employed by countries throughout Europe.